Reporters.io
Luke Halpern, Assistant Editor
Pharmacy Times
Profile
Contacts
Recent Articles on Subject
1
Luke Halpern, Assistant Editor
Pharmacy Times
IVIG Prophylaxis Significantly Reduces Hospital Admissions for Fever in Pediatrics With ALL
- 5 days ago
Key Drugs to Watch in Oncology, Hematology, and Neurology for 2025
- 5 days ago
FDA Approves Acalabrutinib With Bendamustine, Rituximab For Patients With Previously Untreated Mantle Cell Lymphoma
- 5 days ago
COVID-19 Infection Associated With Higher Likelihood of Developing Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- 6 days ago
Transfusing More Blood to Heart Attack Patients With Anemia Reduces Risk of Death
- 14 days ago
Fear of COVID-19 Among Post-Infected Adults Can Impact Quality of Life
- 15 days ago
Relacorilant NDA Submitted to FDA for Treatment of Endogenous Hypercortisolism
- 16 days ago
Intravenous Immunoglobulin Shows Efficacy as Adjunctive Therapy for Treatment of Pyoderma Gangrenosum
- 18 days ago
Anemia in Patients With Cancer Causes Significant Fatigue, Impacting Quality of Life
- 19 days ago
Majority of Children, Young Patients With Long COVID Recover Within 2 Years
- 20 days ago
MRX-5 Receives FDA Orphan Drug Designation for Treatment of Non-Tuberculous Mycobacteria Infections
- 20 days ago
ASH 2024: Zanubrutinib Monotherapy, With Obinutuzimab Demonstrates Durable Efficacy and Safety in CLL/SLL
- 22 days ago
Updated BNT162b2 XBB COVID-19 Vaccine Protects Against Hospitalization in Children Aged 5 to 17
- 25 days ago
ASH 2024: Cilta-Cel Achieves Sustained MRD Negativity in Patients With Multiple Myeloma
- 27 days ago
Dupilumab Lowers Incidence of Psychiatric and Sleep Disorders in Patients With Atopic Dermatitis
- 29 days ago
Mild IVIG-Related Adverse Events Are Frequent in Children, With Serious Reactions Possible
- 29 days ago
FDA Approves Vibegron for Men With Overactive Bladder Symptoms Receiving Therapy for Benign Prostatic Hyperplasia
- 29 days ago
FDA Approves First Generic of Liraglutide Injection to Lower Blood Sugar in Patients With Type 2 Diabetes
- 30 days ago
ASH 2024: Nuvisertib Demonstrates Durable Response in Relapsed/Refractory Myelofibrosis
- about 1 month ago
Sacituzumab Govitecan-hziy Receives FDA Breakthrough Therapy Designation for Extensive-Stage Small Cell Lung Cancer Treatment
- about 1 month ago
IVIG Identified as a Treatment Marker of High Medical Costs, Resource Utilization in Patients With Myasthenia Gravis
- about 1 month ago
FDA Grants Breakthrough Therapy Designation to Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosis
- about 1 month ago
ASH 2024: Expert Discusses Challenges, Future Research Opportunities With Bispecific Antibodies in Multiple Myeloma
- about 1 month ago
ASH 2024: Rapid Uptake of Bispecific Antibodies for R/R Multiple Myeloma Observed in Community Oncology Settings
- about 1 month ago
ASH 2024: New Treatments in Trial Pipeline Show Promising Survival Rates in R/R Multiple Myeloma
- about 1 month ago
ASH: Zanubrutinib Demonstrates Long-Term Efficacy in Patients With Waldenström Macroglobulinemia
- about 1 month ago
ASH 2024: Pharmacists Play Key Role in Incorporating Venetoclax, Blinatumomab for Treatment of Hematologic Malignancies
- about 2 months ago
ASH: Cilta-Cel Significantly Increases Minimum Residual Disease Negativity in Lenalidomide-Refractory Multiple Myeloma
- about 2 months ago
ASH Expert: Axi-Cel Treatment Causes Decreased Incidence, Severity of Toxicities in Large B-Cell Lymphoma
- about 2 months ago
ASH 2024: Bispecific Antibodies Face Key Challenges for Implementation in Community Cancer Centers
- about 2 months ago
ASH 2024: Leukemia Biology Can Predict Patterns of Blinatumomab Failure in Patients with B-Cell ALL
- about 2 months ago
ASH 2024: Expert Highlights Zanubrutinib's Sustained Efficacy, Favorable Safety Profile in CLL
- about 2 months ago
Make Vaccination Easy: Jerome Adams' Call to Health Care Workers This Flu, COVID-19 Season
- about 2 months ago
NABP Executive Director Encourages Self-Care, Proper Work-Life Balance Among Burnt-Out Pharmacy Workforce
- about 2 months ago
High-Dose IVIG, Rituximab Effective in Patients With Pemphigoid-Associated Conjunctivitis
- about 2 months ago
'We Need to Educate': NABP Seeks to Address Pharmacy Workforce Burnout Through Collaboration, Education
- about 2 months ago
Childhood Pneumococcal Vaccination Programs Indirectly Protect Adults From Pneumococcal Disease
- about 2 months ago
Recent Intravenous Immunoglobulin Administration Can Lead to Serum Protein Electrophoresis Misdiagnosis
- about 2 months ago
COVID-19 Incidence Among Children Not Related to Elementary School Attendance
- about 2 months ago
Childhood Air Pollution Exposure Associated With Higher Risk, Persistence of Peanut Allergy
- about 2 months ago
Decision to Receive Pneumococcal Vaccine Among Older Adults Is Multi-Factorial, Influenced by Multidimensional Interventions
- 2 months ago
FDA Grants Rare Pediatric Disease, Fast Track Designations to Gildeuretinol for Stargardt Disease Treatment
- 2 months ago
Novel IVIG Formulation KIG10 Is Effective, Well Tolerated in Adults With Primary Immunodeficiency
- 2 months ago
Pharmacy Students Using TikTok to Take Learning to the Next Level
- 2 months ago
Nasal Swab Test Can Predict COVID-19 Severity Through Autoantibody Analysis
- 2 months ago
Early Asthma Onset Associated With Memory and Executive Function Difficulties in Children
- 2 months ago
FDA Grants Fast Track Designation to Potential Gene Therapy for Osteoarthritis of the Knee
- 2 months ago
Hoxb8 Mast Cell Activation Test Demonstrates Diagnostic Precision for Assessment of Peanut Allergy
- 2 months ago
Lumateperone Demonstrates Positive Efficacy for Schizophrenia Relapse Prevention
- 2 months ago
FDA Approves Obecabtagene Autoleucel for Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
- 2 months ago
2
Kennedy Ferruggia, Assistant Editor
Pharmacy Times
#pharmacy news, insights. CE provider.
Cranbury, New Jersey
pharmacy
healthcare
journalism
Pharmacy Students Using TikTok to Take Learning to the Next Level
- 2 months ago